Therapeutic use of intermittent fasting for people with type 2 diabetes as an alternative to insulin

This case series documents three patients referred to the Intensive Dietary Management clinic in Toronto, Canada, for insulin-dependent type 2 diabetes. It demonstrates the effectiveness of therapeutic fasting to reverse their insulin resistance, resulting in cessation of insulin therapy while maint...

Descripción completa

Detalles Bibliográficos
Autores principales: Furmli, Suleiman, Elmasry, Rami, Ramos, Megan, Fung, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Myth Exploded
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194375/
https://www.ncbi.nlm.nih.gov/pubmed/30301822
http://dx.doi.org/10.1136/bcr-2017-221854
_version_ 1783364220977414144
author Furmli, Suleiman
Elmasry, Rami
Ramos, Megan
Fung, Jason
author_facet Furmli, Suleiman
Elmasry, Rami
Ramos, Megan
Fung, Jason
author_sort Furmli, Suleiman
collection PubMed
description This case series documents three patients referred to the Intensive Dietary Management clinic in Toronto, Canada, for insulin-dependent type 2 diabetes. It demonstrates the effectiveness of therapeutic fasting to reverse their insulin resistance, resulting in cessation of insulin therapy while maintaining control of their blood sugars. In addition, these patients were also able to lose significant amounts of body weight, reduce their waist circumference and also reduce their glycated haemoglobin level.
format Online
Article
Text
id pubmed-6194375
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-61943752018-10-24 Therapeutic use of intermittent fasting for people with type 2 diabetes as an alternative to insulin Furmli, Suleiman Elmasry, Rami Ramos, Megan Fung, Jason BMJ Case Rep Myth Exploded This case series documents three patients referred to the Intensive Dietary Management clinic in Toronto, Canada, for insulin-dependent type 2 diabetes. It demonstrates the effectiveness of therapeutic fasting to reverse their insulin resistance, resulting in cessation of insulin therapy while maintaining control of their blood sugars. In addition, these patients were also able to lose significant amounts of body weight, reduce their waist circumference and also reduce their glycated haemoglobin level. BMJ Publishing Group 2018-10-09 /pmc/articles/PMC6194375/ /pubmed/30301822 http://dx.doi.org/10.1136/bcr-2017-221854 Text en © BMJ Publishing Group Limited 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Myth Exploded
Furmli, Suleiman
Elmasry, Rami
Ramos, Megan
Fung, Jason
Therapeutic use of intermittent fasting for people with type 2 diabetes as an alternative to insulin
title Therapeutic use of intermittent fasting for people with type 2 diabetes as an alternative to insulin
title_full Therapeutic use of intermittent fasting for people with type 2 diabetes as an alternative to insulin
title_fullStr Therapeutic use of intermittent fasting for people with type 2 diabetes as an alternative to insulin
title_full_unstemmed Therapeutic use of intermittent fasting for people with type 2 diabetes as an alternative to insulin
title_short Therapeutic use of intermittent fasting for people with type 2 diabetes as an alternative to insulin
title_sort therapeutic use of intermittent fasting for people with type 2 diabetes as an alternative to insulin
topic Myth Exploded
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194375/
https://www.ncbi.nlm.nih.gov/pubmed/30301822
http://dx.doi.org/10.1136/bcr-2017-221854
work_keys_str_mv AT furmlisuleiman therapeuticuseofintermittentfastingforpeoplewithtype2diabetesasanalternativetoinsulin
AT elmasryrami therapeuticuseofintermittentfastingforpeoplewithtype2diabetesasanalternativetoinsulin
AT ramosmegan therapeuticuseofintermittentfastingforpeoplewithtype2diabetesasanalternativetoinsulin
AT fungjason therapeuticuseofintermittentfastingforpeoplewithtype2diabetesasanalternativetoinsulin

Ejemplares similares